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Zfp516, a brown fat (BAT)-enriched and cold-induc-
ible transcription factor, promotes transcription of
UCP1 and other BAT-enriched genes for non-shiv-
ering thermogenesis. Here, we identify lysine-spe-
cific demethylase 1 (LSD1) as a direct binding partner
of Zfp516. We show that, through interaction with
Zfp516, LSD1 is recruited to UCP1 and other BAT-
enriched genes, such as PGC1a, to function as a co-
activator by demethylating H3K9. We also show that
LSD1 is induced during brown adipogenesis and that
LSD1 and its demethylase activity is required for the
BAT program. Furthermore, we show that LSD1 abla-
tion in mice using Myf5-Cre alters embryonic BAT
development. Moreover, BAT-specific deletion of
LSD1 via the use of UCP1-Cre impairs the BAT pro-
gram and BAT development, making BAT resemble
WAT, reducing thermogenic activity and promoting
obesity. Finally, we demonstrate an in vivo require-
ment of the Zfp516-LSD1 interaction for LSD1 func-
tion in BAT gene activation.
INTRODUCTION
Unlike white adipose tissue (WAT), whose main function is to
store energy in the form of triacylglycerol that is to be used during
energy deprivation, brown adipose tissue (BAT) is specialized
in heat production for maintenance of body temperature via
non-shivering thermogenesis. Since the discovery that active
brown-adipose-like tissue is present in adults (Cypess et al.,
2009; Farmer, 2009; van Marken Lichtenbelt et al., 2009; Virta-
nen et al., 2009) and that BAT can have anti-obesity and anti-
diabetic effects (Lowell et al., 1993; Enerba¨ck et al., 1997; Bartelt
et al., 2011), mechanisms underlying BAT formation and function
have attracted a growing interest in obesity research.
BAT displays high mitochondrial density and contains uncou-
pling protein 1 (UCP1). UCP1, a proton transporter, uncouples
the mitochondrial proton gradient from ATP synthesis, dissi-
pating energy as heat for non-shivering thermogenesis. UCP12536 Cell Reports 15, 2536–2549, June 14, 2016 ª 2016 The Authors
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UCP1 transcription is regulated by various transcription factors,
such as PPARg, PGC1a, and ATF2, which can bind to an up-
stream enhancer region of the UCP1 promoter (Collins et al.,
2010; Kang et al., 2005). We recently identified a cold-inducible
transcription factor, Zfp516, which is enriched in BAT and acti-
vates UCP1 and other BAT-enriched genes, such as PGC1a,
to promote a BAT program (Dempersmier et al., 2015). We
have shown that Zfp516 activates UCP1 promoter by binding
to the proximal region and promotes brown adipogenesis.
Consequently, ablation of Zfp516 in mice, although embryoni-
cally lethal, showed a drastically reduced BAT depot formation,
whereas overexpression of Zfp516 in adipose tissue caused
browning of inguinal WAT (iWAT) with increased energy expendi-
ture, preventing diet-induced obesity.
In addition to transcription factors and coregulators, histone
modifications (including methylation, phosphorylation, and acet-
ylation) affect chromatin architecture for epigenetic regulation of
transcription. LSD1 (also called KDM1A or AOF2) was the first
identified histone demethylase, establishing histone methylation
as a reversible and dynamic regulatory mechanism for transcrip-
tion (Wang et al., 2007). LSD1 catalyzes demethylation through a
flavin adenosine dinucleotide (FAD)-dependent oxidative reac-
tion and was initially characterized to target mono- and di-meth-
ylatedK4 residues of histoneH3 (H3K4-1me and -2me) (Shi et al.,
2004) for transcriptional repression. However, LSD1 has also
been shown to promote gene activation through H3K9 demethy-
lation (Metzger et al., 2005). Moreover, LSD1 has been reported
toplay a role during early stagesofwhite adipocyte differentiation
by demethylating H3K9-2me at the C/EBPa promoter region
(Musri et al., 2010). Recently, it has been reported that LSD1 is
not only essential for early steps ofwhite adipocyte differentiation
but promotes oxidative metabolism by interacting with Nrf1
for mitochondrial biogenesis (Duteil et al., 2014). However, the
LSD1 function in BAT and whether it can affect UCP1 or BAT
gene program remain unclear.
Here, we identify LSD1 as a binding partner of Zfp516. LSD1,
which is induced during brown adipogenesis, is recruited to the
UCP1 promoter via direct interaction with Zfp516 for transcrip-
tional activation by H3K9 demethylation at the UCP1 promoter
region. We also show that LSD1 is required for a BAT gene
program, and thus, BAT-specific ablation of LSD1 impairs BATcreativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. LSD1 Directly Interacts with
Zfp516
(A) Immunoblot using aFLAG (Top) or aMyc (Cen-
ter) after immunoprecipitation with either aMyc
or aFLAG, respectively, of HEK293FT cell lysates
transfected with FLAG-Zfp516 and c-Myc-LSD1
either together or individually. (Bottom) Immuno-
blot for endogenous LSD1 after immunoprecipita-
tion of lysates from differentiated BAT cells or BAT
tissue with a-Zfp516 is shown.
(B) (Top) Schematic representation of GST-LSD1
deletion constructs. (Center) Coomassie staining
for indicated GST constructs is shown. (Bottom)
Autoradiograph of GST pull-down using GST
fusion proteins containing the indicated domains
of LSD1 and 35S-labeled in-vitro-translated Zfp516
is shown. Solid line shows lane position moved
within the same blot.
(C) Immunoblot using aMyc (top-left) or aFLAG
(top-right) after immunoprecipitation with either
aFLAG or aMyc, respectively, of lysates from
293FT cells transfected with FLAG-Zfp516 and
either Myc-LSD1 full-length (FL) or deleted Myc-
DLSD1 1–474 (D), together or individually. Immu-
noblots of input for the corresponding lysate are
shown on bottom-left and -right.
See also Figure S1.program and development in mice. Moreover, we also demon-
strate that Zfp516 interacts with LSD1 to promote browning of
iWAT in vivo.
RESULTS
We previously reported Zfp516 as a cold-inducible BAT-en-
riched transcription factor that promotes a BAT gene program.
As a DNA-binding protein, Zfp516may interact with coregulators
to activate BAT transcription. Thus, we investigated potential
interacting partners of Zfp516 to better understand molecular
mechanisms underlying the transcriptional activation of UCP1
and other BAT-enriched genes for promotion of a BAT program.
Direct Interaction between LSD1 and Zfp516
In order to identify Zfp516 binding partners, we used a streptavi-
din- and calmodulin-binding epitope-tag strategy for tandem
affinity purification (TAP) followed by mass spectrometry (MS)
analysis. The Zfp516-interacting proteins were purified from ly-
sates prepared from 293FT cells overexpressing Zfp516 tagged
with streptavidin- and calmodulin-binding peptides. Lysates
from cells overexpressing either TAP alone (empty vector) or
TAP-tagged-Zfp516 (TAP-Zfp516) were processed for affinity
purification. Eluted proteins were then separated by SDS-
PAGE and stained with Coomassie blue (Figure S1A). BandsCell Rdetected only in TAP-Zfp516 lane were
excised and subjected to MS. LSD1 was
identified as a candidate-interacting part-
ner of Zfp516.
In order to validate the interaction
between LSD1 and Zfp516, we first per-formed a coimmunoprecipitation (coIP) using 293FT cells trans-
fected with FLAG-tagged-Zfp516 and Myc-tagged-LSD1 either
alone or in combination (Figure 1A, top). Indeed, by using FLAG
and Myc antibodies, we detected an interaction between
Zfp516 and LSD1 only when coexpressed together. We then
confirmed interaction between endogenous Zfp516 and LSD1,
using lysates from differentiated brown adipocytes as well as
BAT from mice. Immunoprecipitation with Zfp516 or LSD1 anti-
body followed by immunoblotting with LSD1 or Zfp516 antibody,
respectively, clearly detected interaction between the two pro-
teins (Figures 1A, bottom, and S1B). Next, we asked whether
LSD1 binds Zfp516 directly, by using glutathione S-transferase
(GST) fused to LSD1 that was expressed and purified from
E. coli (Figure 1B, top). By incubating GST-LSD1 fusion protein
immobilized onGlutathione Sepharose beadswith in-vitro-trans-
lated Zfp516, we indeed detected direct interaction between
Zfp516 and full-length LSD1 (FL) (Figure 1B, bottom). Further-
more, the use of various GST-LSD1 fragments in the GST
assays indicated that LSD1 directly interacts with Zfp516
through a domain located within the C-terminal region of LSD1,
aa474–852, containing a part of the tower and amine-oxidase-
like (AOL)-C-terminal enzymatic domain (Figure 1B, bottom).
Furthermore, when coexpressed with FLAG-Zfp516, the
construct lacking aa474–852 (DLSD1 1–474) did not coim-
munoprecipitate with Zfp516 (Figure 1C, right). Conversely,eports 15, 2536–2549, June 14, 2016 2537
immunoprecipitation by FLAG antibody detected LSD1 FL, but
not DLSD1 1–474 (Figure 1C, left). We conclude that deletion
of aa474–852 of LSD1 prevents the interaction of LSD1 with
Zfp516. Altogether, these experiments demonstrate the interac-
tion of Zfp516with LSD1 through theC-terminal domain of LSD1.
In this regard,wepreviously have reported that Zfp516directly in-
teracts with PRDM16 (Dempersmier et al., 2015). Here, by coIP,
we also could detect LSD1 interaction with PRDM16 (Figures
S1B and S1C). Overall, these results suggest that, by interacting
with Zfp516, PRDM16 and LSD1 are both recruited to the pro-
moter region of UCP1 or other BAT-enriched genes.
ByBinding to Zfp516, LSD1 Is Recruited to andActivates
the UCP1 Promoter
We previously reported that Zfp516 is recruited to the promoter
regions of UCP1 and other BAT-enriched genes, such as
PGC1a, for promoter activation. In testing the effect of LSD1
on UCP1 and other BAT genes, we performed luciferase reporter
assay using5.5 kbUCP1 promoter (Figure 2A, top) and2.4 kb
PGC1a promoter (Figure 2A, bottom). Along with the luciferase
promoter constructs, Zfp516 and LSD1 were cotransfected,
either alone or in combination, into 293FT cells and luciferase ac-
tivity was measured for quantification. As we previously re-
ported, we observed that Zfp516 activated UCP1 and PGC1a
promoter (Figure 2A, top and bottom). In addition, LSD1 alone
could also activate these promoters (Figure 2A, top and bottom).
More importantly, cotransfection of the promoter constructs with
both Zfp516 and LSD1 further increased promoter activity.
These results show that Zfp516 and LSD1 work together to acti-
vate BAT gene promoters. We next employed two shorter con-
structs of the UCP1 promoter, which contains Zfp516 binding
sequence but lacking the enhancer region of the UCP1 promoter
(70 bp construct), as well as the UCP1 promoter that does
not contain neither Zfp516 binding sequence nor the UCP1
enhancer (45 bp construct; Figure 2B). We found that promoter
activation by Zfp516 and LSD1 was detected when cotrans-
fected with the 70-bp construct, but not with the 45-bp
construct. These results are consistent with the notion of
Zfp516-LSD1 interaction mediating LSD1 activation of UCP1
promoter. We next asked whether LSD1-mediated promoter
activation requires enzymatic activity of LSD1 by using a phar-
macologic inhibitor of LSD1, 2PCPA, in the reporter assay (Fig-
ure 2C). We observed that activation of UCP1 promoter by
LSD1 alone or in combination with Zfp516, but not by Zfp516
alone, was greatly reduced in the presence of 2PCPA, indicating
the requirement of LSD1 demethylase activity for LSD1 effect on
UCP1 promoter activity. In addition, we examined the require-
ment of Zfp516-LSD1 interaction for promoter activation by
cotransfecting 293FT cells with Zfp516 and LSD1 FL or LSD1
deleted of Zfp516 interacting domain, DLSD1 1–474 (Figure 2D).
We observed a significant decrease in promoter activation for
both UCP1 (Figure 2D) and PGC1a (Figure S2B) promoter
when Zfp516 binding domain was deleted. Because DLSD1
1–474 exhibits similar demethylase activity than LSD1 FL (Fig-
ure S2C), this experiment demonstrates the requirement for
Zfp516-LSD1 interaction for promoter activation.
Because LSD1 interacts with Zfp516 and induces UCP1 pro-
moter activity, we predicted that LSD1 should occupy the2538 Cell Reports 15, 2536–2549, June 14, 2016same region that Zfp516 binds within the UCP1 promoter. We
performed chromatin immunoprecipitation (ChIP) using BAT
cells infected with Zfp516 and LSD1 adenoviruses (Figure 2E).
Using FLAG (for Zfp516) and LSD1 antibodies, we detected an
enrichment of the 70-bp region of the UCP1 promoter region
in comparison to the 5.5-kb region that was used as a control
(Figure 2E, left). Quantification by qPCR (primers listed in
Table S1) confirmed a 5- and 4-fold enrichment for Zfp516 and
LSD1 binding, respectively, to the 70-bp UCP1 promoter re-
gion (Figure 2E, center). We next performed reChIP experiment
using Zfp516 and LSD1 antibodies sequentially as indicated
(Figure 2E, right). We observed enrichment for the70-bp region
of the UCP1 promoter when we first used Zfp516 antibody fol-
lowed by LSD1 antibody, as well as when we first used LSD1
antibody followed by Zfp516 antibody, whereas no enrichment
was observed in the control, GAPDH promoter.
Finally, we tested the requirement of Zfp516 for the LSD1
recruitment to the 70-bp UCP1 promoter region (Figure 2F,
left). We compared LSD1 recruitment to the UCP1 promoter re-
gion by ChIP using BAT cells in which LSD1 was overexpressed
but Zfp516 was knocked down by small hairpin RNA (shRNA)
(Figure S2D). We observed a significant decrease in LSD1 bind-
ing to the 70-bp region in Zfp516 knockdown cells compared
to control cells (Figure 2F, left), whereas there was no binding
at the control 5.5-kb region (Figure 2F, right), indicating that
Zfp516 is required for LSD1 recruitment to the UCP1 promoter
in brown adipocytes.
Transcriptional activation by LSD1 has been shown to be
dependent on the demethylation of mono- and di-methylated
H3K9 residue (Metzger et al., 2005). Hence, by ChIP, we as-
sessed methylation status of different lysine residues at the
UCP1 promoter region (Figure 2G). We compared samples
fromBAT of mice with BAT-specific LDS1 deletion and their con-
trol (fl/fl; described below). We detected higher mono- and di-
methylation of H3K9 at the70-bp region of the UCP1 promoter
in BAT from LSD1 knockout (KO) mice (Figure 2G, left). In
contrast, H3K9-3me and H3K4-2me at the 70-bp UCP1 pro-
moter region were affected to a lesser extent or not significantly
affected (Figure 2G, left). Besides, levels of mono- and di-
methylation of H3K9 at the 70-bp region were 8- to 10-fold
higher compared to the 5.5-kb promoter region (Figure 2G,
right). These observations indicate that LSD1 KO affects lysine
methylation specifically at the 70-bp region, consistent with
specific LSD1 binding to this region of UCP1 promoter (Fig-
ure 2E). Overall, these results support the notion that LSD1 par-
ticipates in transcriptional activation by modifying histone
methylation at the promoter region of BAT-specific UCP1 gene.
Altogether, we conclude that LSD1 is recruited by and cooper-
ates with Zfp516 for the activation of UCP1 promoter. Notably,
this activation by LSD1 correlates with demethylation of mono-
and di-methylated H3K9 at the promoter region.
LSD1 Is Required for the BAT Gene Program and BAT
Development In Vivo
We previously reported that Zfp516 activates UCP1 and other
BAT-enriched genes. Thus, Zfp516 ablation causes a decrease
in BAT mass with a greatly lower expression of UCP1 and other
BAT-enriched genes. If Zfp516 recruits LSD1 for its function,
(legend on next page)
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LSD1 should also affect expression of BAT-enriched genes. We
first compared LSD1 mRNA levels between the stromal vascular
fraction (SVF) containing preadipocytes with adipocyte fraction
from BAT of 10-week-old wild-type (WT) mice (Figure 3A). As
predicted, Pref-1 was found to be higher by 75% in the SVF,
whereas UCP1, perilipin, and Zfp516 were 5-, 5-, and 3-fold en-
riched in adipocyte fraction, respectively. We found LSD1 to be
enriched by 4-fold in adipocyte fraction compared to the SVF,
implicating an induction of LSD1 during brown adipogenesis.
We therefore examined LSD1 mRNA and protein levels during
brown adipocyte differentiation of BAT cells in vitro (Figure 3C).
As expected, during brown adipocyte differentiation, we
observed an increased expression of BAT-enriched genes,
such as PGC1a, PRDM16, and Cox8b (Figure 3C, top), as
well as common adipocyte differentiation markers, such as
PPARg, FABP4, and adiponectin (AdipoQ; Figure 3C, top).
More importantly, LSD1 mRNA level was significantly increased
by 5-fold and LSD1 protein level was increased as well, during
differentiation (Figure 3C, bottom). We conclude that LSD1 is
induced during brown adipocyte differentiation and, thus,
LSD1 is enriched in mature brown adipocytes. We also
compared expression of LSD1 and Zfp516 in BAT from WT
mice after a 6-hr cold exposure at 4C (Figure 3B). As expected,
Zfp516, as well as UCP1 and PGC1a, mRNA levels in BAT were
higher by 2.5- to 10-fold upon cold exposure, whereas PRDM16
did not change. Similar to Zfp516, LSD1 mRNA level in BAT was
higher by 3-fold upon cold exposure (Figure 3B). Overall, LSD1
expression pattern is similar to Zfp516 in terms of enrichment in
mature brown adipocytes and induction by cold, which further
supports a cooperative role of LSD1 and Zfp516 for the BAT
program.
We next examined the role of LSD1 and its activity during
brown adipocyte differentiation in vitro. We treated the cells
with two different inhibitors of LSD1, 2PCPA and LSD1i, during
brown adipocyte differentiation (Figure 4A). Compared to control
vehicle-treated cells, cells treated with LSD1 inhibitors showed
lower lipid accumulation (Figure 4A, left-top). Moreover, LSD1 in-
hibition caused a significant reduction of UCP1 at mRNA (Fig-
ure 4A, right) and protein (Figure 4A, left-bottom) levels, as well
as decreased expression of other BAT-enriched genes, such
as PGC1a, Dio2, PRDM16, Cox8b, and Cidea, by 50%–80%Figure 2. Zfp516 Recruits LSD1 to Activate the UCP1 Promoter
(A) (Top) Luciferase activity in 293FT cells cotransfected with the5.5-kb UCP1 p
either together or individually. (Bottom) Luciferase activity in cells cotransfected
either together or individually is shown.
(B) Luciferase activity in cells cotransfected with the 5.5-kb, 70-bp, or 45-bp
individually.
(C) Luciferase activity in cells cotransfected with the 5.5-kb UCP1 promoter an
treatment with LSD1 inhibitor (2PCPA 1 mM) or vehicle for 48 hr.
(D) Luciferase activity in cells cotransfected with the 5.5-kb UCP1 promoter an
(E) (Left) ChIP for Zfp516 and LSD1 binding at the70-bp region of UCP1 promot
and LSD1 adenoviruses. The5.5-kb region of UCP1 promoter was used as a ne
and LSD1 binding to the UCP1 promoter region in BAT cells using immunoglobu
(F) (Left) ChIP for Zfp516 and LSD1 binding to the70-bp region of the UCP1 prom
Zfp516 knockdown (shZfp516), compared to negative control (shGFP). (Right) G
(G) ChIP analysis of histone H3 methylations at the70-bp region of UCP1 promo
tissue from control (fl/fl) or LSD1 KO (LSD1KO) mice.
Data are represented as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001. See al
2540 Cell Reports 15, 2536–2549, June 14, 2016(Figure 4A, right), whereas PPARg was not affected. These re-
sults show that LSD1 demethylase activity is required for expres-
sion of BAT-enriched genes and thus BAT gene program.
To further establish the requirement of LSD1 for the BAT gene
program and to rule out any off-target effects of LSD1 inhibitors,
we next performed adenoviral shRNA-mediated knockdown
of LSD1 (Figure 4B). LSD1 was reduced at mRNA (by 70%) as
well as at protein level in LSD1-shRNA-infected cells (Figure 4B,
left). After 6 days of differentiation, we detected a significantly
lower lipid accumulation in shLSD1 cells compared to the con-
trol, sh-scrambled cells (Figure 4B, center). Expression level of
BAT-enriched genes, such as UCP1, PGC1a, PRDM16, and
Cox8b, was lower by 60%–70% (Figure 4B, right-top), whereas
common adipose markers, PPARg and FABP4, were not
affected significantly (Figure 4B, right-bottom). The results
were confirmed at the protein level. UCP1 and PGC1a levels
were drastically reduced, whereas PPARg level did not change
(Figure 4B, left). Taken together, these results demonstrate
that LSD1 expression and its enzymatic activity are required
for a BAT gene program.
It has been previously reported that global LSD1 KO is lethal
by embryonic day 7.5, which prevents further examination of
BAT development or function (Wang et al., 2007). Therefore, to
evaluate the role of LSD1 in BAT in vivo, we performed a tis-
sue-specific conditional KO of LSD1 using the Cre-lox strategy.
We first attempted to generate conditional LSD1 KO mice by
crossing LSD1-floxed mice with those bearing the Cre recombi-
nase driven by the Myf5 promoter (Tallquist et al., 2000), an
established marker of brown adipose precursors (Seale et al.,
2008). However, we found that LSD1-Myf5KO resulted in peri-
natal lethality preventing the study of BAT function in adults.
Regardless, we could clearly detect a drastic decrease in the
size of BAT depot in Myf5KO newborns compared to control
littermates (fl/fl; Figure 4C, left), although the global size of the
newborns remained the same (data not shown). LSD1 mRNA
level was decreased by 63% in BAT of Myf5KO mice (Figure 4C,
left). We also detected a significant decrease in mRNA levels
of BAT-enriched genes, such as UCP1, PGC1a, C/EBPb, and
Cox8b, by 25%–60% in BAT of Myf5KO newborns, whereas
common adipose markers, such as PPARg and AdipoQ, were
not significantly affected (Figure 4C, right). Thus, we concluderomoter or empty vector (EV), along with Zfp516 and LSD1 expression vectors
with the 2.4-kb PGC1a promoter or EV along with Zfp516 and LSD1 vectors
UCP1 promoter or EV, along with Zfp516 and LSD1 vectors either together or
d EV, along with Zfp516 and LSD1 vectors either together or individually after
d EV, along with Zfp516 and either LSD1 FL or deleted DLSD1 1–474.
er using both aFlag and aLSD1 for chromatin of BAT cells infected with Zfp516
gative control. (Center) qPCR of ChIP DNA is shown. (Right) ReChIP for Zfp516
lin G (IgG), aZfp516, or aLSD1 as indicated are shown.
oter in BAT cells using both aZfp516 and aLSD1with LSD1 overexpression and
APDH promoter was used as a negative control.
ter (Left) or at the GAPDH promoter as a negative control (Right) in ChIP of BAT
so Figure S2.
Figure 3. LSD1 Is Increased during Brown Adipocyte Differentiation and Induced by Cold Exposure in BAT
(A) qRT-PCR for indicated gene in the adipocyte fraction and SVF from BAT.
(B) qRT-PCR for indicated gene in BAT of WT mice exposed to cold (4C) for 6 hr.
(C) (Top) qRT-PCR for indicated gene in BAT cells at days 0, 2, and 5 after the start of differentiation. (Bottom) LSD1mRNA level (Top) and immunoblot (Bottom) for
indicated proteins in BAT cells at days 0, 2, and 5 of differentiation are shown.
Data are represented as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001.that LSD1 ablation in brown adipose precursors impairs embry-
onic development of BAT in vivo.
LSD1 Promotes a BAT Gene Program and
Thermogenesis In Vivo
To further evaluate the role of LSD1 in BAT development and its
function in vivo, we performed conditional KO of LSD1 using
different Cre mice to overcome perinatal lethality of our Myf5KO
model (Figure 4C). Because UCP1 has been shown to expressearly during BAT development, we next employed UCP1-Cre.
Crossing LSD1-floxed mice with mice carrying the UCP1 pro-
moter-Cre (Kong et al., 2014) produced BAT-specific KO mice
(BSKO) at room temperature, allowing us to examine the role
of LSD1 in BAT. In addition to genotyping, we further validated
our mouse model by measuring LSD1 mRNA levels in BAT of
LSD1-BSKO and LSD1fl/fl control (fl/fl) mice. LSD1 mRNA level
was decreased by 65% in BAT, but not in WAT depots, iWAT
and perigonadal WAT (pWAT) (Figure 5B, top-left). Similarly,Cell Reports 15, 2536–2549, June 14, 2016 2541
Figure 4. LSD1 Is Required for the BAT Program and BAT Development
(A) (Left-top) ORO staining and bright-field view (203 magnification) of BAT cells treated with vehicle (left panel) or LSD1 inhibitors: 2PCPA (Center) and LSD1i
(Right), at day 6 of differentiation. (Left-bottom) Immunoblotting for indicated proteins in lysates from BAT cells at day 6 is shown. (Right) qRT-PCR for indicated
genes in BAT cells treated with vehicle (Left) or LSD1 inhibitors at day 6 is shown.
(B) (Left) qRT-PCR for LSD1mRNA in BAT cells infected with control scrambled (shscr) or shLSD1 adenovirus at day 6 (Top). Immunoblot for indicated proteins in
BAT cells at day 6 (Bottom) is shown. (Center) ORO staining and bright-field views (203magnification) of BAT cells infected with control shscr (Left) or shLSD1
(Right) adenovirus at day 6 are shown. (Right) qRT-PCR for indicated genes in BAT cells infected with control shscr or shLSD1 adenovirus at day 6 is shown.
(legend continued on next page)
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LSD1 protein level was reduced only in BAT, but not in liver,
iWAT, or pWAT (Figure 5B, top-right), showing the BAT speci-
ficity of the model.
LSD1-BSKOmice exhibited a significantly higher body weight
by approximately 4 g than control littermates (Figure 5A, top) at
14 weeks, whereas food intake was not affected (Figure S3A).
Their BAT depot was bigger but pale (right) in comparison to
control mice (left; Figure 5A, top). Body composition analysis
indicated that, whereas fat mass was increased, lean mass re-
mained the same in BSKO mice (Figure 5A, center and bottom).
Histological analysis of the BAT depot from BSKO mice had
noticeable morphological differences. H&E staining showed
BAT of BSKOmice exhibited bigger lipid droplets in comparison
to control littermates (Figure 5C, center). Interestingly, whereas
BAT from control mice presented brown adipocytes with small
lipid droplets, which is typical of BAT, BAT from BSKO mice ex-
hibited adipocytes containing bigger lipid droplets. Morphology
of WAT, as demonstrated with H&E staining of pWAT sections,
was unchanged (Figure 5C, top). Furthermore, expression levels
of BAT-enriched genes, such as PGC1a, UCP1, CideA, and
Cox8b, were lower by 55%–30% (Figure 5B, center), whereas
common adipocyte markers, PPARg, FABP4, AdipoQ, and
perilipin, were not affected (Figure 5B, bottom). Immunoblots
showed a strong reduction of UCP1 at the protein level only in
BAT and not inWAT, whereas PPARg remained unchanged (Fig-
ure 5B, top-right). Similarly, immunostaining for UCP1 showed
a correspondingly lower staining in BSKO compared to control
mice (Figure 5C, bottom). Collectively, BAT of LSD1-BSKO
mice lost the major BAT phenotypic characteristics of brown
coloration, presence of multiple lipid droplets within smaller
adipocytes, and BAT gene expression pattern. Moreover, not
only did we observe a loss of BAT characteristics, but we
also observed a switch toward a more-white-adipose-specific
morphology of bigger lipid droplet size with increased lipid
content. Overall, these results demonstrate that LSD1 ablation
causes a whitening of BAT, establishing in vivo requirement of
LSD1 for a normal BAT program.
Considering that LSD1-BSKO mice had no change in food
intake but exhibited a higher body weight, we next investigated
whether energy expenditure could be altered. We first evaluated
thermogenic capacity by measuring body temperature. We
found that LSD1-BSKO mice had a lower body temperature
than control mice at room temperature, and this difference in
body temperature was further enhanced after a 6-hr cold expo-
sure (Figure 5D). These results suggest an impaired thermogenic
function of BSKOmice. Indeed, indirect calorimetry showed that
oxygen consumption (VO2) was significantly reduced in BSKO
mice compared to WT mice at room temperature, whereas res-
piratory ratio and locomotor activity were unchanged (Figures
5E, left, S3B, and S3C). Similar reduction in oxygen consumption
was observed at thermoneutrality (30C), as well as at 4C
(Figure S3D). Taken together, we conclude that energy expen-(C) (Top-left) Representative photograph of control (fl/fl) and LSD1fl/fl-Myf5Cre (My
qRT-PCR for LSD1 mRNA in BAT of control and Myf5KO embryos (n = 8–9 embry
sections of the interscapular region of control andMyf5 KO embryos (P0) is shown
common adipose genes (Bottom) in BAT of control or Myf5KO embryos (n = 8–9
Data are represented as mean ± SEM.*p < 0.05; **p < 0.01; ***p < 0.001.diture estimated by oxygen consumption was decreased in
LSD1-BSKO mice compared to control mice. To examine the
contribution of BAT to the altered energy expenditure in BSKO
mice, we next measured oxygen consumption rate (OCR) of
BAT dissected out from these LSD1-BSKO mice (Figure 5E,
right). Indeed, we found significantly lower OCR in BAT from
BSKO mice by 35% in comparison to that from control mice.
In line with these results, BSKO mice gained more body weight
on high-fat diet (HFD) than their control littermates, demon-
strating a propensity for obesity upon BAT-specific LSD1 dele-
tion (Figure 5F, left). In addition, blood glucose level of BSKO
mice on HFD measured in the course of a glucose tolerance
test (GTT) was significantly higher than in control littermates (Fig-
ure 5F, right), indicative of an impaired glucose tolerance. Collec-
tively, these data establish a defective BAT function in BSKO
mice and that LSD1 ablation reduced thermogenic capacity
in vivo. Furthermore, in evaluating the role of LSD1 in BAT, we
also generated LSD1 conditional KO mice by mating the LSD1-
floxed mice with AdipoQ-Cre mice (Eguchi et al., 2011) for
LSD1 KO in all adipose tissue depots BAT, iWAT and pWAT
(ASKO mice; Figure S4). We found the phenotype of these
ASKO mice to be quite similar to that in BSKO mice (Figure S4),
thus further confirming the critical role of LSD1 for BAT function.
In Vivo Requirement of LSD1-Zfp516 Interaction
To demonstrate the significance of LSD1-Zfp516 interaction, we
tested LSD1 requirement in the context of Zfp516-induced
browning of iWAT. In this regard, we previously have shown
that overexpression of Zfp516 in adipose tissue causes
browning of iWAT. In testing the requirement of LSD1 on
Zfp516-induced browning, we performed a LSD1 knockdown
in 3T3-L1 cells overexpressing Zfp516 (AdZfp516) or a control
empty GFP vector (AdGFP) (Figure 6A). We verified Zfp516 over-
expression and LSD1 knockdown at both mRNA (35- to 40-fold
and 70%, respectively) and protein levels (Figure 6A, top). We
observed that induction of BAT-enriched genes by Zfp516
overexpression was impaired in LSD1 shRNA knockdown cells
(shLSD1) compared to control shRNA (shscr) cells, as indicated
by approximately 50% decrease in mRNA levels for PGC1a,
UCP1, andCidea (Figure 6A, bottom), aswell as strong reduction
of UCP1 at protein level (Figure 6A, top-right). Next, to evaluate
the requirement of LSD1 within in vivo setting, we performed im-
plantation experiments using Zfp516-overexpressing 3T3-L1
cells coinfected with shLSD1 or control shscr (Figure 6B). After
7 days, implants along with pWAT as a control were collected
and analyzed. Zfp516 overexpression and LSD1 knockdown
were validated at the mRNA levels, as indicated by 8- to 10-
fold increase in Zfp516 mRNA level and 55% decrease in
LSD1 in knockdown implants (Figure 6B, left-top). The expres-
sion of BAT-enriched genes, such as PGC1a, UCP1, Elovl3,
and Dio2, was greatly reduced in shLSD1 knockdown implants
compared to control, at a level close to that in pWAT depotf5KO) newborn embryos (P0) from back view. Black dots delineate area of BAT.
os per group) is shown. (Bottom-left) H&E staining of representative transversal
. Black dots delineate area of BAT. (Right) qRT-PCR for BAT-enriched (Top) and
embryos per group) is shown.
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Figure 5. LSD1 Promotes a BAT Gene Program In Vivo
(A) (Top-left) Representative photograph of control and LSD1 BSKO 17-week-old mice and their BAT depot. (Top-right) Body weight of 14-week-old control and
LSD1 BSKO mice is shown. (Center) Fat and lean mass of 14-week-old control and LSD1 BSKO mice determined using EchoMRI is shown. (Bottom) Mass of
adipose depots from mice described above is shown.
(legend continued on next page)
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(Figure 6B, right-top). However, we did not observe any differ-
ence in PPARg expression between these implants (Figure 6B,
right-bottom). Moreover, histological analysis of implant sec-
tions showed a global increase in adipocyte size, as well as
decreased UCP1 staining in shLSD1 implants (Figure 6B, left-
bottom). These results suggest that Zfp516 and LSD1 cooperate
together to activate BAT-enriched genes in white adipocytes,
thereby changing their characteristics toward a brown
morphology. Furthermore, upon exposure of LSD1-ASKO mice
at 4C for 6 hr, we observed expression of BAT-enriched genes,
such as PGC1a, UCP1, and Cox8b, was lower not only in BAT
(Figures S5A and S5C) but also iWAT of ASKO mice in compar-
ison to control littermates (Figures S5A and S5B). These results
demonstrate a role for LSD1 in cold-induced browning of
iWAT, in addition to promotion of thermogenic program in BAT
as shown above. To address the relevance of Zfp516-LSD1
interaction for iWAT browning in a more physiologically relevant
system, we generated an additional mouse model by crossing
aP2-Zfp516 transgenic mice overexpressing Zfp516 in all adi-
pose depots with LSD1-ASKOmice with LSD1 ablation in all ad-
ipose depots (Figure 6C). We verified Zfp516 overexpression
and LSD1 ablation in iWAT of aP2-Zfp516, aP2-Zfp516 ASKO,
and their control littermates (fl/fl). We detected a 160- to 200-
fold increase in Zfp516 expression and 60% lower LSD1 expres-
sion, respectively, in these mice (Figure 6C, left-top). Zfp516
overexpression and LSD1KO in iWATwere confirmed at the pro-
tein level (Figure S6B). We found that induction of BAT-enriched
genes, including UCP1, Cox8b, and PGC1a, by Zfp516 in iWAT
was blunted upon LSD1 ablation, whereas adipose common
markers for WAT and BAT, such as PPARg and AdipoQ, re-
mained unchanged (Figure 6C, right). Histological analysis of
iWAT sections showed that LSD1 ablation prevented morpho-
logical changes (smaller lipid droplets) and UCP1 staining arising
from Zfp516 overexpression in aP2-Zfp516-LSD1-ASKO mice
(Figure 6C, left-bottom). In comparison, there was no drastic
change in either morphology or UCP1 staining in pWAT (Fig-
ure S6A). Moreover, as expected, LSD1 ablation also reduced
the expression of BAT-enriched genes in BAT of aP2-Zfp516
mice (Figure S6C). Collectively, these results demonstrate the
role of LSD1 in the induction of the BAT program and browning
of iWAT in vivo and, more importantly, the biological significance
of LSD1-Zfp516 interaction in these processes.
DISCUSSION
In the present study, we demonstrate that Zfp516, previously es-
tablished as a transcriptional activator of UCP1 and other BAT-(B) (Top) qRT-PCR for LSD1 mRNA in adipose tissue depots of control and LSD1
pWAT of control and LSD1 BSKO mice (Right). (Center) qRT-PCR for BAT-enrich
for common adipose genes in BAT of control and LSD1 BSKO mice is shown.
(C) H&E staining of pWAT sections from control and LSD1 BSKOmice (Top). H&E
control and LSD1 BSKO mice are shown.
(D) (Top) Body temperature from control and LSD1 BSKO mice at 23C and afte
(E) (Left) VO2 consumption measured by indirect calorimetry in control and LSD
group). (Right) Oxygen consumption rate (OCR) of BAT from control and LSD1 B
(F) (Left) Bodymass gain of control and BSKOmice under HFD starting at 6 weeks
mice under HFD for 10 weeks is shown (n = 6–8 mice per group).
The scale bars represent 200 mm. Data are represented as mean ± SEM. *p < 0.enriched genes, directly interacts with LSD1. Zfp516 recruits
LSD1 on the promoter regions of BAT genes, and they work
together for transcriptional activation of BAT genes. In this
context, LSD1 works as a coactivator for the regulation of BAT
genes through its demethylase activity on H3K9. We establish
both in vitro and in vivo that LSD1 is crucial for the BAT program
for proper development and function of BAT. Altogether, our
data establish that LSD1 is a cold-induced histonemodifier inter-
acting with Zfp516, a BAT-enriched transcription factor, for its
recruitment and thereby regulates transcription of BAT genes.
We demonstrate here the requirement of LSD1 for Zfp516 func-
tion in inducing a BAT program to promote thermogenic function
of BAT and also browning of iWAT.
Whereas LSD1 has been initially described as a component of
a repressor complex by removing active epigenetic marks by
demethylating H3K4 (H3K4-1me and -2me), it has also been re-
ported that LSD1 can act as a coactivator by demethylating
H3K9 (H3K9-1me and -2me). We show here that, in the context
of BAT gene regulation, LSD1 works as a coactivator recruited
by Zfp516, and we detected increased H3K9-1me and H3K9-
2me, but not of H3K4-1me and H3K4-2me, at the promoter re-
gion of UCP1 in BAT of LSD1 KOmice. We observed no increase
but rather a decrease in H3K4-1me in LSD1 BSKO BAT, which
may have resulted from altered expression or activity of other
methylase(s) due to impaired brown adipogenesis. In this regard,
G9a methyltransferase has been reported to induce PPARg
expression during both white and brown adipogenesis by meth-
ylating H3K9-1me (Wang et al., 2013). EHMT1, a methyltransfer-
ase that has recently been shown to regulate brown adipose
cell fate, may also affect histone modification (Ohno et al.,
2013). Considering that many methylases and demethylases
act together to regulate histone methylation for transcriptional
activation, the decrease observed in H3K4-1me is likely an indi-
rect effect of LSD1 KO on other histone methylases at the
same region of UCP1 promoter. Notably, it has been reported
that LSD1 affects histone methylation status in association
with SETDB1 histone methylase on C/EBPa promoter during
white adipogenesis (Musri et al., 2010). Regardless, histone de-
methylases and methyltransferases may target the same resi-
dues to maintain a tightly regulated balance between activating
and repressive epigenetic marks on BAT gene promoters.
Our results suggest that LSD1 activates UCP1 and other BAT
genes, such as PGC1a, probably by demethylating H3K9-1me
and H3K9-2me, which are known to be epigenetic repressive
marks. It remains unclear how LSD1 mediates transcription
repression or activation, either by demethylating H3K4 or
H3K9, respectively. Recently, it has been reported that anBSKO mice (Left) and immunoblot for indicated proteins BAT, liver, iWAT, and
ed genes in BAT of control and LSD1 BSKO mice is shown. (Bottom) qRT-PCR
staining (Center) and immunostaining for UCP1 (Bottom) of BAT sections from
r a 6-hr cold exposure at 4C.
1 BSKO mice on chow diet (NCD) at room temperature (23C; n = 7 mice per
SKO mice.
of age (n = 6–8 mice per group). (Right) GTT on 16-week-old control and BSKO
05; **p < 0.01; ***p < 0.001. See also Figure S3.
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isoform of LSD1, LSD1+8a arising from alternative splicing, does
not retain any enzymatic activity toward H3K4-2me and hence
regulates neuronal differentiation solely through demethylation
of H3K9-2me (Laurent et al., 2015). Another study documented
LSD1+8a to demethylate H4K20, which was associated with
memory and learning process (Wang et al., 2015). Regardless,
we could not detect LSD1+8a isoform either in BAT or in differ-
entiated BAT cells (data not shown). Such a versatile substrate
specificity of LSD1 remains to be elucidated. We propose that
Zfp516 controls LSD1 specificity by recruiting it to chromatin
to demethylate H3K9 at the promoter regions for BAT develop-
ment and function.
We show here that Zfp516 directly interacts with LSD1,
thereby recruiting it to the promoter regions of UCP1 or other
BAT-enriched genes. Thus, LSD1 activates thermogenic genes,
such as UCP1 and PGC1a, for BAT program. Interestingly,
Duteil et al. (2014), globally overexpressed LSD1 in mice and
reported that LSD1 promotes oxidative capacities in WAT by
interaction with nuclear respiratory factor 1 (Nrf1) for mitochon-
drial biogenesis. In the same study, LSD1 was reported also to
induce Nrf1 expression for the observed effect. Due to the
global overexpression of LSD1 in these mice, however, specific
role of LSD1 in WAT was not clear. In this regard, we previously
have shown that Zfp516 overexpression in adipose tissue
causes browning of iWAT. We cannot rule out that LSD1
may function by interacting with multiple partners. However,
because LSD1 directly interacts with Zfp516 and both of these
genes are cold-inducible, iWAT browning may be mediated by
LSD1-Zfp516 interaction. Indeed, we found that knockdown of
LSD1 in 3T3-L1 cells prevented Zfp516-induced BAT gene acti-
vation, indicating involvement of Zfp516-LSD1 interaction in this
process (Figure 6A). LSD1 ablation prevents Zfp516-induced
browning of implanted 3T3-L1 cells (Figure 6B) but also of
iWAT in aP2-Zfp516 LSD1 ASKO mice (Figure 6C). Hence, we
show here that LSD1 is required for browning of iWAT through
its interaction with Zfp516. Not only LSD1 but Zfp516 also
have multiple interacting partners. We previously reported
that Zfp516 directly interacts with PRDM16 for transcriptional
activation of UCP1 and other BAT-enriched genes, such as
PGC1a. Here, we confirmed that LSD1 interacts with PRDM16
(Figure S1B). More importantly, we demonstrate that Zfp516
function requires interaction with LSD1. Therefore, we propose
that multiple coregulators, such as LSD1 and PRDM16, interact
with Zfp516 in inducing BAT genes for BAT program and
thermogenesis.
In order to examine the role of LSD1 during BAT development
in vivo, we first attempted at generating LSD1 conditional KO inFigure 6. Zfp516-LSD1 Interaction Is Required for Browning of iWAT
(A) (Top) qRT-PCR for LSD1 and Zfp516mRNA in 3T3-L1 cells coinfected with eith
of differentiation (left). Immunoblot for indicated proteins in lysates from infecte
infected 3T3-L1 cells at day 7 is shown.
(B) (Left) qRT-PCR for LSD1 and Zfp516 mRNA in implants and pWAT from mice
AdZfp516 + shLSD1 (Top). H&E staining (Top) and immunostaining for UCP1 (B
qRT-PCR for BAT-enriched genes and adipose common genes in implants and
(C) (Left) qRT-PCR for LSD1 and Zfp516 mRNA in iWAT from 8-week-old control
staining (Top) and immunostaining for UCP1 (Bottom) in sections of iWAT from m
PCR for BAT-enriched or common adipose genes in iWAT from mice described
Data are represented as mean ± SEM.*p < 0.05; **p < 0.01; ***p < 0.001. See alsbrown adipose precursors usingMyf5-Cremice. However, LSD1
Myf5KO mice were found to die perinatally. Such an early
lethality might have resulted from the fact that, besides brown
adipose precursors, Myf5+ cells are early mesenchymal progen-
itors giving rise to myocytes, cartilage, and dermis. Interestingly,
LSD1 has been shown to regulate myogenesis through regula-
tion of MyoD and Mef2 expression (Choi et al., 2010) as well as
thyroid hormone signaling (Ambrosio et al., 2013). We propose
that survival of LSD1 Myf5KO pups was probably compromised
not only by impaired thermoregulation but also by defects in
development of other tissues. Unlike previously characterized
ASKOmice using aP2 promoter, which were shown to be devoid
of WAT (Duteil et al., 2014), our ASKOmice with adiponectin-Cre
promoter exhibited an increase in WAT mass. Considering that
AdipoQ is expressed later than aP2/FABP4 during development,
LSD1 may be crucial only for early steps of WAT development,
which is in accordance with previously reported in vitro studies
(Duteil et al., 2014). We predict that impaired BAT development
and function in thesemicemay have caused increase in lipid con-
tent and depot size of WAT as a compensatory mechanism.
Regardless, we cannot rule out other role of LSD1 in WAT, such
as that reported by Duteil et al. As is the case of coregulators in
general, LSD1 may function with other transcription factors,
such asNrf1, inWAT to alter fatty acid (FA) oxidation and thus lipid
content. The use of UCP1-Cre allows ablation of LSD1 in BAT
(UCP1+ cells specifically), whenmice aremaintained at room tem-
perature. Upon cold exposure, LSD1 could be ablated in subcu-
taneous WAT depots of BSKO mice also, with the appearance
of UCP1-expressing beige cells. BAT-conditional KO (BSKO
mice) shows a stronger phenotype in BAT and WAT than Myf5-
PRDM16KO. Indeed, Harms et al. (2014) reported that Myf5-
PRDM16 KO mice exhibit a late-onset decrease of thermogenic
markers in BAT, suggesting that PRDM16 is dispensable for early
BAT development but required for BAT identity maintenance.
However, they suggested compensatory activity of PRDM3
in PRDM16 KO mice and reported a stronger phenotype in
PRDM16/PRDM3 double KOmice. Similarly, UCP1 KOmice (En-
erba¨ck et al., 1997) phenotype is milder than LSD1 BSKO. How-
ever, only UCP1 is deleted and, as the authors indicated, UCP2
was induced for compensation. These points may explain the dif-
ferences in phenotype severity. However, we also suggest that,
because of Zfp516-LSD1 interaction, the phenotypewe observed
in LSD1BSKO is also due to the impaired Zfp516 function for acti-
vation of UCP1 and BAT-enriched genes and BAT development.
In conclusion, our results support the idea that BAT develop-
ment and function require the concerted action of transcriptional
regulators as well as chromatin modifiers. We establish that, noter control AdGFP or AdZfp516 and control shscr or shLSD1 adenovirus at day 7
d 3T3-L1 cells at day 7 (right). (Bottom) qRT-PCR for BAT-enriched genes in
implanted with 3T3-L1 cells infected with either AdZfp516 + shscr (control) or
ottom) of sections of implants described above (Bottom) are shown. (Right)
pWAT described above (n = 6 mice per group).
(fl/fl), aP2-Zfp516, and aP2-Zfp516 ASKO mice (n = 6–8 mice per group). H&E
ice described above are shown. The scale bars represent 200 mm. (Right) qRT-
above is shown.
o Figures S4–S6.
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only is LSD1 required for BAT development, but it is also a major
activator of BAT-enriched genes through its interaction with
Zfp516, thereby regulating thermogenesis. As both Zfp516 and
LSD1 are cold inducible, it reinforces the idea that their interplay
is essential for cold adaptation. Thus, Zfp516 directly interacts
with LSD1 and recruits it to BAT gene promoters, where it deme-
thylates H3K9 residues. Together, they promote a BAT gene pro-
gram and regulate both development and thermogenic function
of BAT as well as browning of iWAT.
EXPERIMENTAL PROCEDURES
Animals
Mice carrying floxed LSD1 alleles (KDM1a fl/fl), UCP1-Cre, adiponectin-Cre
(AQ-Cre), Myf5-Cre transgenic, and Swiss SWR/J mice were obtained from
The Jackson Laboratory. aP2-Zfp516 transgenic mice were described previ-
ously (Dempersmier et al., 2015). All protocols for mice studies were approved
from the University of California at Berkeley Animal Care and Use Committee.
Mice were fed a chow diet or an HFD (45% calorie from fat; Research Diet) ad
libitum. Body weight and food intake were measured weekly. See also Supple-
mental Experimental Procedures.
Cell Transplantation
3T3-L1 cells expressing Luciferin were implanted in Swiss SWR/J-recipient
mice using amatrix-assisted cell transplantation strategy described previously
(Tharp et al., 2015). Briefly, 3T3-L1 Luc cells were infected with AdZfp516 and
either Adshscr or AdshLSD1 as in Orlicky and Schaack (2001). Forty-eight
hours post-infection, cells were resuspended in hydrogel at 3 3 106 cells/ml
and 100 ml was injected into subcutaneous inguinal region of recipient mice.
After 7 days, implants were collected along with pWAT for further mRNA
extraction and histological analysis.
Body Composition and Histology
Body composition was measured in non-anesthetized mice using MRI
(EchoMRI). For histology, fresh tissues were fixed in 4% paraformaldehyde,
embedded in paraffin, sectioned in 5-mM-thick sections, and stained with H&E.
For immunohistochemistry, fresh tissues were fixed in 7% glutaraldehyde,
included in optimal cutting temperature compound (OCT), and sectioned on
Leica CM3050SCryostat in 20-mm-thick sections further incubatedwith aUCP1.
Indirect Calorimetry, Explant Respiration, and Body Temperature
Oxygen consumption (VO2) was measured using the Comprehensive Labora-
tory Animal Monitoring System (CLAMS) (Colombus Instruments). Data were
normalized to lean body mass determined by EchoMRI. Tissue explant respi-
ration was measured using a XF24 Analyzer (Seahorse Bioscience). Briefly, 3-
to 5-mg pieces of tissue were placed into KREB’s-Heslinger buffer in XF-24
plates with an islet capture screen and incubated for 1 hr at 37C without
CO2 prior to analysis. Body temperature was assessed using a RET-3 rectal
probe for mice (Physitemp).
GTTs
For GTTs, mice were fasted overnight. Glucose (1 mg/g) was administered
intraperitoneally. Blood glucose was measured at indicated time.
Statistical Analysis
Data are expressed asmeans ±SEM. The statistical differences inmean values
were assessed by Student’s t test. The sample size was six to eight per geno-
type for animal studies and three to six for protein and transcript. All experi-
ments were performed at least three times, and representative data are shown.
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